U.S.A.Breakthrough therapy designation approval and its implications for new drugs review in China
YUAN Lin
SHAO Ming-li
Keywords：breakthrough therapynew drugs reviewexpedited reviewserious diseasesnew drug application
Publication Date：2017-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)